External site

By following this link, you are leaving Medically and entering a website that is not owned or controlled by Roche. Roche does not take any responsibility for access to or use of this website, nor for any content therein.

Leave site
Roche and Genentech at

APVRS 2025

We will be contributing to topics related to
-
05:36 PM
Duration 6mins Manila, Philippines
Update on Faricimab▼ for Diabetic Macular Edema: New Clinical Features of Eyes in the RHONE-X Long-Term Extension Study
Young Hee Yoon
Notify me

Sign up or login to unlock the full suite of MEDICALLY features

Add to calendar
06:00 PM
Duration 6mins Manila, Philippines
Four-Year Outcomes of Faricimab▼ in nAMD: Safety and Efficacy Results From the AVONELLE-X Long-Term Extension Trial
Timothy Lai
Notify me

Sign up or login to unlock the full suite of MEDICALLY features

Add to calendar
06:18 PM
Duration 6mins Manila, Philippines
Greater Anatomical Improvements With Faricimab▼ vs Aflibercept 8 Weeks After Injections: A TENAYA/LUCERNE Post Hoc Analysis
Tai-Chi Lin
Notify me

Sign up or login to unlock the full suite of MEDICALLY features

Add to calendar
Duration 6mins Manila, Philippines
Long-Term Efficacy and Safety of the Port Delivery Platform With Ranibizumab in Patients With nAMD: Results from Ladder- and Archway-to-Portal Studies
Yew Sen Yuen
Notify me

Sign up or login to unlock the full suite of MEDICALLY features

Add to calendar
11:48 PM
Duration 6mins Manila, Philippines
Real-World Outcomes of Faricimab▼ in Patients With nAMD and DME From a Global, Prospective Observational Study: The VOYAGER Study
Voraporn Chaikitmongkol
Notify me

Sign up or login to unlock the full suite of MEDICALLY features

Add to calendar
05:00 PM
Duration 6mins Manila, Philippines
Association of Early Macular Leakage Resolution With Extended Dosing Intervals in Patients With Retinal Vein Occlusion: A Post Hoc Analysis of the BALATON/COMINO Trials
Hemal Mehta
Notify me

Sign up or login to unlock the full suite of MEDICALLY features

Add to calendar
05:30 PM
Duration 6mins Manila, Philippines
Faricimab▼ for Polypoidal Choroidal Vasculopathy: 1-Year Results From the Phase 3b/4 SALWEEN Trial
Gemmy Cheung
Notify me

Sign up or login to unlock the full suite of MEDICALLY features

Add to calendar
07:00 PM
Duration 6mins Manila, Philippines
Effectiveness and Safety of Faricimab▼ in Eyes With Neovascular Age-Related Macular Degeneration and Diabetic Macular Edema Beyond Year 1: Results From the UK FARWIDE-nAMD and FARWIDE-DME Study
Kenneth Fong
Notify me

Sign up or login to unlock the full suite of MEDICALLY features

Add to calendar
08:00 PM
Duration 6mins Manila, Philippines
Baseline and Early Treatment Response Variables Associated With Faricimab▼ Durability in Treatment-Naïve nAMD: TENAYA/LUCERNE Post Hoc Analyses
Marie Joan Loy
Notify me

Sign up or login to unlock the full suite of MEDICALLY features

Add to calendar
10:00 PM
Duration 6mins Manila, Philippines
Evaluation of the Role of Interleukin-6 and Vascular Endothelial Growth Factor in Uveitic Macular Edema and Uveitis
Yih-Shiou Hwang
Notify me

Sign up or login to unlock the full suite of MEDICALLY features

Add to calendar
10:06 PM
Duration 6mins Manila, Philippines
Interleukin-6 Inhibition With Vamikibart in Patients With Uveitic Macular Edema: Data from Phase 3 MEERKAT and SANDCAT Trials
Yew Sen Yuen
Notify me

Sign up or login to unlock the full suite of MEDICALLY features

Add to calendar
Coming soon